Economic portfolio
SBI Healthcare Opportunities Fund
SBI SBI Mutual Fund Jan 2022 — Sep 2026 57 months
Data periodFund holdingsSep 2026NSE prices23 Oct 2026Data status →
Days to sell half: 14.3 — selling half of every holding at 20% of each stock’s usual daily NSE trading, the time to get through 90% of the portfolio (Sep 2026). Takes days, not hours, to unwind. Small-cap comparison →
Shares of this fund’s disclosed Indian listed equity, valued at official NSE closing prices. Cash, debt, derivatives and overseas holdings are not included, so for a hybrid or debt fund these are shares of its equity part only. Not performance, and not a recommendation.
How concentrated it has been
57 priced months, Jan 2022 to Sep 2026 · at each month’s NSE closes
Top 10 holdings, share of equity
54.2% now, 53.2% in Sep 2025 · highest 77.3%, lowest 53.2%
Companies held
35 now, 29 in Sep 2025 · largest single holding 11.7% of equity
How long new positions last: of the 20 companies this fund started holding between Nov 2022 and Aug 2025, 75% were still held a year later — it usually keeps what it buys. Across active funds the figure is about 50%, and a fund’s figure has stayed similar from year to year. A description of how the fund is run, not of its results. How this was tested →
How it trades: leans toward adding to shares that fell over the previous six months (score -0.16 over 24 months; −1 always buys the biggest fallers, +1 the biggest risers, 0 no pattern). Value and contra funds average −0.10, other active funds about 0. A description of behaviour, not of results. How this was tested →
Sector mix
Share of the equity shown · NSE industry
Funds most like this one
Overlap of disclosed equity · the smaller share of each company both hold, added up
- Mirae Asset Nifty 500 Healthcare ETFMirae Asset · 26 shared64.1%
- WhiteOak Capital Pharma and Healthcare FundWhiteOak Capital · 27 shared62.1%
- Bandhan BSE Healthcare Index FundBandhan · 33 shared61.8%
- Motilal Oswal BSE Healthcare ETFMotilal Oswal · 33 shared61.8%
- Mirae Asset Healthcare FundMirae Asset · 17 shared59.9%
- EODWHFEdelweiss · 16 shared58.9%
- Axis NIFTY Healthcare ETFAxis · 14 shared56.2%
- ICICI Prudential Nifty Healthcare ETFICICI Prudential · 14 shared56.2%
Select one to see exactly what the two funds share. Index funds and ETFs tracking the same index overlap almost completely.
What changed in Sep 2026
This portfolio’s consecutive disclosures · evidenced adjustments applied
New positions
Complete exits
- None this month.
Largest increases
Largest reductions
Share quantities, not market values or cash flows.
Holdings by value
Sep 2026 · largest 100 · share of the equity shown
| Company | Sector | Size | Share of equity | Value | Shares held | Held since |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | Healthcare | Large Cap | 11.66% | 654 Cr | 0.36 Cr | by Jan 2022 (57 mo+) |
| Divi's Laboratories Limited | Healthcare | Large Cap | 8.28% | 465 Cr | 0.05 Cr | by Jan 2022 (57 mo+) |
| Acutaas Chemicals Limited | Healthcare | Small Cap | 5.26% | 295 Cr | 0.09 Cr | Jun 2024 (28 mo) |
| Apollo Hospitals Enterprise Limited | Healthcare | Large Cap | 4.66% | 261 Cr | 0.03 Cr | Jan 2026 (9 mo) |
| Torrent Pharmaceuticals Limited | Healthcare | Large Cap | 4.62% | 259 Cr | 0.05 Cr | by Jan 2022 (57 mo+) |
| Cipla Limited | Healthcare | Large Cap | 4.61% | 258 Cr | 0.19 Cr | May 2026 (5 mo) |
| Laurus Labs Limited | Healthcare | Mid Cap | 4.24% | 238 Cr | 0.12 Cr | Aug 2023 (38 mo) |
| Max Healthcare Institute Limited | Healthcare | Large Cap | 3.98% | 223 Cr | 0.24 Cr | by Jan 2022 (57 mo+) |
| Aurobindo Pharma Limited | Healthcare | Mid Cap | 3.58% | 201 Cr | 0.12 Cr | Mar 2026 (7 mo) |
| Aster DM Quality Care Limited | Healthcare | Small Cap | 3.36% | 188 Cr | 0.27 Cr | Mar 2024 (31 mo) |
| Gland Pharma Limited | Healthcare | Small Cap | 3.10% | 174 Cr | 0.06 Cr | by Jan 2022 (57 mo+) |
| Sudeep Pharma Limited | Chemicals | Small Cap | 2.92% | 164 Cr | 0.14 Cr | Nov 2025 (11 mo) |
| Anthem Biosciences Limited | Healthcare | Mid Cap | 2.88% | 161 Cr | 0.19 Cr | Jul 2025 (15 mo) |
| Sai Life Sciences Limited | Healthcare | Small Cap | 2.72% | 152 Cr | 0.10 Cr | Jan 2026 (9 mo) |
| CORONA Remedies Limited | Not classified | Small Cap | 2.54% | 142 Cr | 0.07 Cr | Sep 2026 (1 mo) |
| Biocon Limited | Healthcare | Mid Cap | 2.48% | 139 Cr | 0.38 Cr | Nov 2024 (23 mo) |
| Fortis Healthcare Limited | Healthcare | Mid Cap | 2.47% | 139 Cr | 0.18 Cr | by Jan 2022 (57 mo+) |
| Concord Biotech Limited | Healthcare | Small Cap | 2.35% | 132 Cr | 0.10 Cr | Nov 2024 (23 mo) |
| Aether Industries Limited | Chemicals | Small Cap | 2.27% | 127 Cr | 0.07 Cr | May 2022 (53 mo) |
| Jupiter Life Line Hospitals Limited | Not classified | Small Cap | 2.26% | 127 Cr | 0.50 Cr | Aug 2023 (38 mo) |
| Poly Medicure Limited | Healthcare | Small Cap | 1.91% | 107 Cr | 0.06 Cr | Aug 2024 (26 mo) |
| Ajanta Pharma Limited | Healthcare | Small Cap | 1.87% | 105 Cr | 0.03 Cr | Feb 2026 (8 mo) |
| Global Health Limited | Healthcare | Mid Cap | 1.83% | 102 Cr | 0.07 Cr | May 2026 (5 mo) |
| Mankind Pharma Limited | Healthcare | Mid Cap | 1.79% | 100 Cr | 0.04 Cr | Apr 2023 (42 mo) |
| Healthcare Global Enterprises Limited | Healthcare | Small Cap | 1.78% | 99.91 Cr | 0.15 Cr | Jul 2026 (3 mo) |
| Krishna Institute of Medical Sciences Limited | Healthcare | Small Cap | 1.77% | 99.36 Cr | 0.13 Cr | Nov 2022 (47 mo) |
| Cohance Lifesciences Limited | Healthcare | Small Cap | 1.74% | 97.68 Cr | 0.22 Cr | Jun 2024 (28 mo) |
| Innova Captab Limited | Not classified | Small Cap | 1.72% | 96.64 Cr | 0.08 Cr | Sep 2026 (1 mo) |
| Dr. Lal Path Labs Ltd. | Healthcare | Small Cap | 1.70% | 95.38 Cr | 0.05 Cr | May 2026 (5 mo) |
| Nephrocare Health Services Limited | Healthcare | Small Cap | 1.18% | 65.97 Cr | 0.10 Cr | Dec 2025 (10 mo) |
| Syngene International Limited | Healthcare | Small Cap | 1.17% | 65.75 Cr | 0.18 Cr | Jul 2026 (3 mo) |
| Rainbow Childrens Medicare Limited | Healthcare | Small Cap | 0.70% | 39.43 Cr | 0.03 Cr | Mar 2026 (7 mo) |
| Gufic Biosciences Limited | Not classified | Small Cap | 0.31% | 17.28 Cr | 0.04 Cr | by Jan 2022 (57 mo+) |
| Abbott India Limited | Healthcare | Mid Cap | 0.24% | 13.56 Cr | 5,000 | by Jan 2022 (57 mo+) |
| Novartis India Limited | Not classified | Small Cap | 0.04% | 2.34 Cr | 12,179 | Sep 2026 (1 mo) |
Half of its current holdings have been held for 23 disclosed months or more without a break. “By” means held in the first month we have for this fund, so possibly for longer. Counted over this fund’s own monthly disclosures; a merger (e.g. HDFC into HDFC Bank, July 2023) starts a new run for the surviving company.
Recent position changes
Latest 100 company-month records · evidenced adjustments applied
| Company | Month | Activity | Adjusted change |
|---|---|---|---|
| Innova Captab Limited | Sep 2026 | ▲ New position | +0.08 Cr |
| CORONA Remedies Limited | Sep 2026 | ▲ New position | +0.07 Cr |
| Healthcare Global Enterprises Limited | Sep 2026 | ▲ Increasing | +0.05 Cr |
| Aurobindo Pharma Limited | Sep 2026 | ▼ Reducing | -0.01 Cr |
| Aether Industries Limited | Sep 2026 | ▼ Reducing | -49,674 |
| Dr. Lal Path Labs Ltd. | Sep 2026 | ▲ Increasing | +40,000 |
| Novartis India Limited | Sep 2026 | ▲ New position | +12,179 |
| Ajanta Pharma Limited | Sep 2026 | ▼ Reducing | -9,591 |
| Abbott India Limited | Sep 2026 | ▼ Reducing | -2,764 |
| Syngene International Limited | Aug 2026 | ▲ Increasing | +0.05 Cr |
| Healthcare Global Enterprises Limited | Aug 2026 | ▲ Increasing | +0.04 Cr |
| Lupin Limited | Aug 2026 | ▼ Complete exit | -0.04 Cr |
| Jupiter Life Line Hospitals Limited | Aug 2026 | ▲ Increasing | +0.03 Cr |
| Fortis Healthcare Limited | Aug 2026 | ▲ Increasing | +0.03 Cr |
| Aster DM Quality Care Limited | Aug 2026 | ▲ Increasing | +0.03 Cr |
| Concord Biotech Limited | Aug 2026 | ▲ Increasing | +0.02 Cr |
| Max Healthcare Institute Limited | Aug 2026 | ▲ Increasing | +0.01 Cr |
| Sun Pharmaceutical Industries Limited | Aug 2026 | ▲ Increasing | +0.01 Cr |
| Dr. Lal Path Labs Ltd. | Aug 2026 | ▲ Increasing | +0.01 Cr |
| Global Health Limited | Aug 2026 | ▲ Increasing | +0.01 Cr |
| Gufic Biosciences Limited | Aug 2026 | ▼ Reducing | -0.01 Cr |
| Cipla Limited | Aug 2026 | ▲ Increasing | +60,000 |
| Nephrocare Health Services Limited | Aug 2026 | ▲ Increasing | +47,101 |
| Torrent Pharmaceuticals Limited | Aug 2026 | ▲ Increasing | +40,000 |
| Apollo Hospitals Enterprise Limited | Aug 2026 | ▲ Increasing | +20,000 |
| Abbott India Limited | Aug 2026 | ▼ Reducing | -12,236 |
| Aurobindo Pharma Limited | Aug 2026 | ▼ Reducing | -1,808 |
| Ajanta Pharma Limited | Aug 2026 | ▼ Reducing | -618 |
| Aether Industries Limited | Aug 2026 | ▼ Reducing | -326 |
| Syngene International Limited | Jul 2026 | ▲ New position | +0.13 Cr |
| Cipla Limited | Jul 2026 | ▲ Increasing | +0.07 Cr |
| Healthcare Global Enterprises Limited | Jul 2026 | ▲ New position | +0.06 Cr |
| Sun Pharmaceutical Industries Limited | Jul 2026 | ▲ Increasing | +0.04 Cr |
| Aether Industries Limited | Jul 2026 | ▼ Reducing | -0.02 Cr |
| Jupiter Life Line Hospitals Limited | Jul 2026 | ▲ Increasing | +0.02 Cr |
| Mankind Pharma Limited | Jul 2026 | ▼ Reducing | -0.02 Cr |
| Nephrocare Health Services Limited | Jul 2026 | ▲ Increasing | +0.02 Cr |
| Torrent Pharmaceuticals Limited | Jul 2026 | ▲ Increasing | +0.01 Cr |
| Global Health Limited | Jul 2026 | ▲ Increasing | +80,000 |
| Divi's Laboratories Limited | Jul 2026 | ▲ Increasing | +50,000 |
| Anthem Biosciences Limited | Jul 2026 | ▲ Increasing | +40,000 |
| Abbott India Limited | Jul 2026 | ▼ Reducing | -4,000 |
| Cipla Limited | Jun 2026 | ▲ Increasing | +0.06 Cr |
| Cohance Lifesciences Limited | Jun 2026 | ▲ Increasing | +0.04 Cr |
| Sun Pharmaceutical Industries Limited | Jun 2026 | ▲ Increasing | +0.02 Cr |
| Alkem Laboratories Limited | Jun 2026 | ▼ Complete exit | -0.02 Cr |
| Krishna Institute of Medical Sciences Limited | Jun 2026 | ▲ Increasing | +0.01 Cr |
| Aether Industries Limited | Jun 2026 | ▼ Reducing | -0.01 Cr |
| Aurobindo Pharma Limited | Jun 2026 | ▲ Increasing | +70,000 |
| Dr. Lal Path Labs Ltd. | Jun 2026 | ▲ Increasing | +60,000 |
| Anthem Biosciences Limited | Jun 2026 | ▲ Increasing | +37,793 |
| Abbott India Limited | Jun 2026 | ▼ Reducing | -1,000 |
| Cohance Lifesciences Limited | May 2026 | ▲ Increasing | +0.08 Cr |
| Cipla Limited | May 2026 | ▲ New position | +0.06 Cr |
| Global Health Limited | May 2026 | ▲ New position | +0.06 Cr |
| Krishna Institute of Medical Sciences Limited | May 2026 | ▼ Reducing | -0.04 Cr |
| Lupin Limited | May 2026 | ▼ Reducing | -0.03 Cr |
| Aurobindo Pharma Limited | May 2026 | ▲ Increasing | +0.03 Cr |
| Dr. Lal Path Labs Ltd. | May 2026 | ▲ New position | +0.02 Cr |
| Gufic Biosciences Limited | May 2026 | ▼ Reducing | -0.02 Cr |
| Anthem Biosciences Limited | May 2026 | ▼ Reducing | -0.02 Cr |
| Medplus Health Services Limited | May 2026 | ▼ Complete exit | -0.01 Cr |
| Aether Industries Limited | May 2026 | ▼ Reducing | -0.01 Cr |
| Mankind Pharma Limited | May 2026 | ▼ Reducing | -80,000 |
| Sanofi Consumer Healthcare India Limited | May 2026 | ▼ Complete exit | -40,000 |
| Alkem Laboratories Limited | May 2026 | ▼ Reducing | -25,000 |
| Vijaya Diagnostic Centre Limited | Apr 2026 | ▼ Complete exit | -0.03 Cr |
| Cohance Lifesciences Limited | Apr 2026 | ▼ Reducing | -0.02 Cr |
| Aurobindo Pharma Limited | Apr 2026 | ▲ Increasing | +0.02 Cr |
| Rainbow Childrens Medicare Limited | Apr 2026 | ▲ Increasing | +0.02 Cr |
| Max Healthcare Institute Limited | Apr 2026 | ▲ Increasing | +0.01 Cr |
| Gufic Biosciences Limited | Apr 2026 | ▼ Reducing | -95,259 |
| Aether Industries Limited | Apr 2026 | ▼ Reducing | -84,798 |
| CORONA Remedies Limited | Apr 2026 | ▼ Complete exit | -75,000 |
| Sai Life Sciences Limited | Apr 2026 | ▲ Increasing | +64,595 |
| Medplus Health Services Limited | Apr 2026 | ▼ Reducing | -50,000 |
| Sanofi Consumer Healthcare India Limited | Apr 2026 | ▼ Reducing | -20,000 |
| Abbott India Limited | Apr 2026 | ▼ Reducing | -5,000 |
| Anthem Biosciences Limited | Apr 2026 | ▲ Increasing | +508 |
| Aurobindo Pharma Limited | Mar 2026 | ▲ New position | +0.08 Cr |
| Anthem Biosciences Limited | Mar 2026 | ▲ Increasing | +0.04 Cr |
| Sun Pharmaceutical Industries Limited | Mar 2026 | ▲ Increasing | +0.03 Cr |
| Max Healthcare Institute Limited | Mar 2026 | ▲ Increasing | +0.03 Cr |
| Gufic Biosciences Limited | Mar 2026 | ▼ Reducing | -0.02 Cr |
| Sai Life Sciences Limited | Mar 2026 | ▲ Increasing | +0.01 Cr |
| Rainbow Childrens Medicare Limited | Mar 2026 | ▲ New position | +0.01 Cr |
| Laurus Labs Limited | Mar 2026 | ▼ Reducing | -0.01 Cr |
| Mankind Pharma Limited | Mar 2026 | ▲ Increasing | +0.01 Cr |
| Medplus Health Services Limited | Mar 2026 | ▼ Reducing | -0.01 Cr |
| Fortis Healthcare Limited | Mar 2026 | ▲ Increasing | +0.01 Cr |
| Aether Industries Limited | Mar 2026 | ▼ Reducing | -80,000 |
| Ajanta Pharma Limited | Mar 2026 | ▲ Increasing | +50,000 |
| Torrent Pharmaceuticals Limited | Mar 2026 | ▼ Reducing | -40,000 |
| Lupin Limited | Mar 2026 | ▼ Reducing | -30,000 |
| Divi's Laboratories Limited | Mar 2026 | ▼ Reducing | -30,000 |
| Pfizer Limited | Mar 2026 | ▼ Complete exit | -30,000 |
| CORONA Remedies Limited | Mar 2026 | ▼ Reducing | -25,000 |
| Sanofi Consumer Healthcare India Limited | Mar 2026 | ▼ Reducing | -15,000 |
| Aurobindo Pharma Limited | Feb 2026 | ▼ Complete exit | -0.07 Cr |
| Ajanta Pharma Limited | Feb 2026 | ▲ New position | +0.03 Cr |
Changes compare consecutive month-end disclosures for this portfolio only.